PGR and cancer: These results support the concept that women with high mammographic density and thus tissue stiffness-driven PR activity may derive greater benefit from anti-progestin therapy that remodels the mammary stroma and reduces the number of cancer-precursor luminal progenitor/LASP cells (Fig. 4i).